PURPOSE: To prospectively determine if gammaH2AX (phosphorylated form of H2AX histone variant)-based visualization and quantification of DNA damage induced in peripheral blood mononuclear cells (PBMCs) can be used to estimate the radiation dose received by adult patients who undergo multidetector computed tomography (CT). MATERIALS AND METHODS: After institutional review board approval and written informed patient consent were obtained, eight women and five men (mean age, 63.8 years) who would be undergoing chest-abdominal-pelvic CT or chest CT only were recruited. Venous blood samples obtained before scanning were exposed to different radiation doses in vitro and incubated for 5-30 minutes to obtain reference values of gammaH2AX focus yield. Additional blood samples were taken 5-30 minutes after CT. Leukocytes were isolated, fixed, and stained for gammaH2AX expression. The gammaH2AX focus yields were determined with fluorescence microscopy, and the radiation doses delivered during CT were estimated by comparing post-CT focus yields with in vitro pre-CT focus yields. These CT radiation doses were compared with doses calculated by using phantom dosimetry and Monte Carlo data sets. Data were analyzed by using linear regression, the dispersion index test, and the contaminated Poisson method. RESULTS: Compared with the gammaH2AX focus yields in blood samples taken before CT (0.06 focus per cell+/-0.01 [mean+/-standard error of mean]), the yields in blood samples taken 5 minutes after chest-abdominal-pelvic CT (0.52 focus per cell+/-0.02) were 8-10-fold higher and corresponded to a mean radiation dose of 16.4 mGy (95% confidence interval: 15.1, 17.7). The mean yield of 0.24 focus per cell+/-0.04 in one patient after chest CT corresponded to a mean radiation dose of 6.3 mGy+/-1.4. In comparison, phantom dosimetry-calculated total blood doses were 13.85 mGy with whole-body CT and 5.16 mGy with chest CT. CONCLUSION: gammaH2AX focus yield in blood cells may be a useful quantitative biomarker of human low-level radiation exposure. Copyright (c) RSNA, 2007.
PURPOSE: To prospectively determine if gammaH2AX (phosphorylated form of H2AX histone variant)-based visualization and quantification of DNA damage induced in peripheral blood mononuclear cells (PBMCs) can be used to estimate the radiation dose received by adult patients who undergo multidetector computed tomography (CT). MATERIALS AND METHODS: After institutional review board approval and written informed patient consent were obtained, eight women and five men (mean age, 63.8 years) who would be undergoing chest-abdominal-pelvic CT or chest CT only were recruited. Venous blood samples obtained before scanning were exposed to different radiation doses in vitro and incubated for 5-30 minutes to obtain reference values of gammaH2AX focus yield. Additional blood samples were taken 5-30 minutes after CT. Leukocytes were isolated, fixed, and stained for gammaH2AX expression. The gammaH2AX focus yields were determined with fluorescence microscopy, and the radiation doses delivered during CT were estimated by comparing post-CT focus yields with in vitro pre-CT focus yields. These CT radiation doses were compared with doses calculated by using phantom dosimetry and Monte Carlo data sets. Data were analyzed by using linear regression, the dispersion index test, and the contaminated Poisson method. RESULTS: Compared with the gammaH2AX focus yields in blood samples taken before CT (0.06 focus per cell+/-0.01 [mean+/-standard error of mean]), the yields in blood samples taken 5 minutes after chest-abdominal-pelvic CT (0.52 focus per cell+/-0.02) were 8-10-fold higher and corresponded to a mean radiation dose of 16.4 mGy (95% confidence interval: 15.1, 17.7). The mean yield of 0.24 focus per cell+/-0.04 in one patient after chest CT corresponded to a mean radiation dose of 6.3 mGy+/-1.4. In comparison, phantom dosimetry-calculated total blood doses were 13.85 mGy with whole-body CT and 5.16 mGy with chest CT. CONCLUSION:gammaH2AX focus yield in blood cells may be a useful quantitative biomarker of human low-level radiation exposure. Copyright (c) RSNA, 2007.
Authors: O Zlobinskaya; G Dollinger; D Michalski; V Hable; C Greubel; G Du; G Multhoff; B Röper; M Molls; T E Schmid Journal: Radiat Environ Biophys Date: 2012-01-07 Impact factor: 1.925
Authors: M A Kuefner; S Grudzenski; J Hamann; S Achenbach; Michael Lell; K Anders; S A Schwab; L Häberle; M Löbrich; M Uder Journal: Eur Radiol Date: 2010-07-13 Impact factor: 5.315
Authors: Johanna Mirsch; Francesco Tommasino; Antonia Frohns; Sandro Conrad; Marco Durante; Michael Scholz; Thomas Friedrich; Markus Löbrich Journal: Proc Natl Acad Sci U S A Date: 2015-09-21 Impact factor: 11.205
Authors: Brunhild M Halm; Adrian A Franke; Jennifer F Lai; Helen C Turner; David J Brenner; Vatche M Zohrabian; Robert DiMauro Journal: Pediatr Radiol Date: 2014-04-23
Authors: Elisa Danese; Giuseppe Lippi; Ruggero Buonocore; Marco Benati; Chiara Bovo; Chiara Bonaguri; Gian Luca Salvagno; Giorgio Brocco; Dirk Roggenbuck; Martina Montagnana Journal: Ann Transl Med Date: 2017-07
Authors: Christophe E Redon; Asako J Nakamura; Ksenia Gouliaeva; Arifur Rahman; William F Blakely; William M Bonner Journal: PLoS One Date: 2010-11-23 Impact factor: 3.240
Authors: Christina Bauerschmidt; Cecilia Arrichiello; Susanne Burdak-Rothkamm; Michael Woodcock; Mark A Hill; David L Stevens; Kai Rothkamm Journal: Nucleic Acids Res Date: 2009-11-11 Impact factor: 16.971